HIWIN MIKROSYSTEM CORPHIWIN MIKROSYSTEM CORPHIWIN MIKROSYSTEM CORP

HIWIN MIKROSYSTEM CORP

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪18.75 B‬TWD
‪5.10 M‬TWD
‪2.17 B‬TWD
‪81.73 M‬
Beta (1Y)
1.42
Employees (FY)
551
Change (1Y)
−69 −11.13%
Revenue / Employee (1Y)
‪3.94 M‬TWD
Net income / Employee (1Y)
‪9.26 K‬TWD

About HIWIN MIKROSYSTEM CORP


CEO
Kuo I Ssu
Headquarters
Taichung
Founded
1997
ISIN
TW0004576004
FIGI
BBG00M979FM9
D Western Therapeutics Institute, Inc is a Japan-based company engaged in the research and development of new pharmaceuticals. The Company generates revenue from licensing of its developed drugs to other companies. As of December 31, 2012, the Company’s drug pipeline included anti-thrombotic medicine K-134, therapeutic agent K-115 for glaucoma, and anticancer drug HMN-214. Its newly-developed products include new anti-thrombotic medicine and signal-transduction inhibitors, including therapeutic agent for high-blood pressure, protective agent for nerves, therapeutic agent for atherosclerosis, ophthalmologic drug and anticancer drug, among others. The Company is also developing new drug candidate compounds focusing on protein kinase inhibitors.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 4576 is 151.0 TWD — it has decreased by −1.60% in the past 24 hours. Watch HIWIN MIKROSYSTEM CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange HIWIN MIKROSYSTEM CORP stocks are traded under the ticker 4576.
4576 stock has risen by 18.92% compared to the previous week, the month change is a 35.09% rise, over the last year HIWIN MIKROSYSTEM CORP has showed a 119.48% increase.
We've gathered analysts' opinions on HIWIN MIKROSYSTEM CORP future price: according to them, 4576 price has a max estimate of 140.00 TWD and a min estimate of 133.00 TWD. Watch 4576 chart and read a more detailed HIWIN MIKROSYSTEM CORP stock forecast: see what analysts think of HIWIN MIKROSYSTEM CORP and suggest that you do with its stocks.
4576 reached its all-time high on Mar 4, 2021 with the price of 177.5 TWD, and its all-time low was 46.0 TWD and was reached on Mar 19, 2020. View more price dynamics on 4576 chart.
See other stocks reaching their highest and lowest prices.
4576 stock is 4.97% volatile and has beta coefficient of 1.42. Track HIWIN MIKROSYSTEM CORP stock price on the chart and check out the list of the most volatile stocks — is HIWIN MIKROSYSTEM CORP there?
Today HIWIN MIKROSYSTEM CORP has the market capitalization of ‪18.75 B‬, it has increased by 23.17% over the last week.
Yes, you can track HIWIN MIKROSYSTEM CORP financials in yearly and quarterly reports right on TradingView.
HIWIN MIKROSYSTEM CORP is going to release the next earnings report on Mar 4, 2025. Keep track of upcoming events with our Earnings Calendar.
4576 earnings for the last quarter are 0.20 TWD per share, whereas the estimation was 0.15 TWD resulting in a 33.33% surprise. The estimated earnings for the next quarter are 0.25 TWD per share. See more details about HIWIN MIKROSYSTEM CORP earnings.
HIWIN MIKROSYSTEM CORP revenue for the last quarter amounts to ‪598.00 M‬ TWD, despite the estimated figure of ‪597.00 M‬ TWD. In the next quarter, revenue is expected to reach ‪593.00 M‬ TWD.
4576 net income for the last quarter is ‪24.29 M‬ TWD, while the quarter before that showed ‪26.70 M‬ TWD of net income which accounts for −9.04% change. Track more HIWIN MIKROSYSTEM CORP financial stats to get the full picture.
Yes, 4576 dividends are paid annually. The last dividend per share was 0.10 TWD. As of today, Dividend Yield (TTM)% is 0.06%. Tracking HIWIN MIKROSYSTEM CORP dividends might help you take more informed decisions.
HIWIN MIKROSYSTEM CORP dividend yield was 0.15% in 2023, and payout ratio reached 234.74%. The year before the numbers were 1.44% and 36.64% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 30, 2024, the company has 551.00 employees. See our rating of the largest employees — is HIWIN MIKROSYSTEM CORP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HIWIN MIKROSYSTEM CORP EBITDA is ‪196.83 M‬ TWD, and current EBITDA margin is 8.87%. See more stats in HIWIN MIKROSYSTEM CORP financial statements.
Like other stocks, 4576 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HIWIN MIKROSYSTEM CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HIWIN MIKROSYSTEM CORP technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HIWIN MIKROSYSTEM CORP stock shows the buy signal. See more of HIWIN MIKROSYSTEM CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.